BOLTON SECURITIES CORPORATION’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$549K Sell
11,462
-2,547
-18% -$109K 0.02% 584
2026
Q1
$515K Buy
+14,009
New +$664K 0.02% 537
2025
Q3
$535K Buy
+9,645
New +$565K 0.03% 497
2025
Q1
$435K Buy
+6,266
New +$518K 0.03% 516

Other funds holding NVO

BOLTON SECURITIES CORPORATION's NVO Position: Q2 2026 in Review

BOLTON SECURITIES CORPORATION reduced its Novo Nordisk (NVO) stake by 18% in Q2 2026, selling an estimated $109K and leaving 11,462 shares worth $549K. The position accounts for 0.02% of the portfolio, ranked #584.

BOLTON SECURITIES CORPORATION first reported a position in NVO in Q1 2025 and has held it in 4 quarters since. 1,362 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • BOLTON SECURITIES CORPORATION held 11,462 shares of Novo Nordisk worth $549K as of Q2 2026.
  • BOLTON SECURITIES CORPORATION sold 2,547 Novo Nordisk shares in Q2 2026, an estimated $109K.
  • Novo Nordisk made up 0.02% of BOLTON SECURITIES CORPORATION's portfolio in Q2 2026, its #584 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Novo Nordisk in Q1 2025 and has held it in 4 quarters since.
  • 1,362 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q2 2026.